Sangamo Therapeutics Inc (NASDAQ:SGMO)
| 3.41 Delayed Data As of Jan 30 |  -0.175 / -4.89%Today’s Change | 2.72 Today|||52-Week Range 6.42 | +8.44% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Biogen Inc |  Sale | 8/29/2022 | 400,000 | $5.33 | $2.1M | -35.24% |
Biogen Inc | Sale | 8/30/2022 | 100,000 | $5.27 | $527.0K | -36.21% |
Macrae Alexander D | Sale | 2/25/2022 | 49,890 | $5.90 | $294.4K | -42.37% |
Ramelmeier R Andrew /sangamo/ EVP-Technical Operations | Sale | 2/25/2022 | 12,388 | $5.90 | $73.1K | -42.37% |
Mcclung Mark D Chief Operating Officer & EVP | Sale | 6/25/2022 | 11,525 | $4.31 | $49.7K | -20.37% |
Fontenot Jason D Senior Vice President & Chief Scientific Officer | Sale | 2/25/2022 | 6,248 | $5.90 | $36.9K | -42.37% |
Mcclung Mark D Chief Operating Officer & EVP | Sale | 2/25/2022 | 4,610 | $5.90 | $27.2K | -42.37% |
Markels John H Director |  Buy | 6/03/2022 | 6,784 | $3.69 | $25.0K | -8.60% |
Durabaibu Prathyusha Vice President-Finance | Sale | 2/25/2022 | 3,474 | $5.90 | $20.5K | -42.37% |
Willoughby Scott B General Counsel & Senior Vice President | Sale | 4/24/2022 | 3,976 | $4.70 | $18.7K | -29.61% |
Page of 4